These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12203221)

  • 1. Endometrioid carcinoma of the endometrium with an invasive component of minimal deviation carcinoma.
    Mai KT; Perkins DG; Yazdi HM; Thomas J
    Hum Pathol; 2002 Aug; 33(8):856-8. PubMed ID: 12203221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
    Tambouret R; Clement PB; Young RH
    Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrioid adenocarcinoma of the uterus with a minimal deviation invasive pattern.
    Landry D; Mai KT; Senterman MK; Perkins DG; Yazdi HM; Veinot JP; Thomas J
    Histopathology; 2003 Jan; 42(1):77-82. PubMed ID: 12493029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Minimal deviation' endometrioid carcinoma with oncocytic change of the endometrium.
    Mai KT; Yazdi HM; Boone SA
    Arch Pathol Lab Med; 1995 Aug; 119(8):751-4. PubMed ID: 7544107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal deviation endometrioid adenocarcinoma of the endometrium and its MRI findings.
    Nakao Y; Yamasaki F; Yokoyama M; Aihara S; Yasunaga M; Iwasaka T
    Eur J Gynaecol Oncol; 2014; 35(2):185-7. PubMed ID: 24772926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
    Fadare O; Parkash V
    Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.
    Demopoulos RI; Mesia AF; Mittal K; Vamvakas E
    Int J Gynecol Pathol; 1999 Jul; 18(3):233-7. PubMed ID: 12092593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunohistochemical discrimination of endometrioid adenocarcinomas.
    Dabbs DJ; Sturtz K; Zaino RJ
    Hum Pathol; 1996 Feb; 27(2):172-7. PubMed ID: 8617459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panel of Villin, Pro-Ex-C, Estrogen Receptor and Progesterone Receptor Expressions Could Help in Differentiation Between Endocervical and Endometrioid Adenocarcinoma.
    Elfeky M; Harb O; Gertallah L
    Turk Patoloji Derg; 2017; 1(1):29-40. PubMed ID: 28832070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrioid Adenocarcinoma With "Burrowing" Invasion of the Cervix Represents a Separate Primary From the Concurrent Uterine Corpus Endometrial Endometrioid Adenocarcinoma: Histology, Immunohistochemistry, and Next-generation Sequencing Study of a Single Case.
    Li Y; Chen J; Niu S
    Int J Gynecol Pathol; 2024 May; 43(3):271-274. PubMed ID: 37922950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
    Taylor J; McCluggage WG
    Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrioid adenocarcinoma arising from endometriosis of the uterine cervix: a case report.
    Park HM; Lee SS; Eom DW; Kang GH; Yi SW; Sohn WS
    J Korean Med Sci; 2009 Aug; 24(4):767-71. PubMed ID: 19654969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.
    Alkushi A; Irving J; Hsu F; Dupuis B; Liu CL; Rijn M; Gilks CB
    Virchows Arch; 2003 Mar; 442(3):271-7. PubMed ID: 12647218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synchronous endometrioid adenocarcinomas in the uterine cervix and corpus.
    Obata T; Nakamura M; Mizumoto Y; Matsumoto T; Takakura M; Fujiwara H
    J Obstet Gynaecol Res; 2016 Oct; 42(10):1390-1394. PubMed ID: 27354119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review.
    Liang SX; Patel K; Pearl M; Liu J; Zheng W; Tornos C
    Int J Gynecol Pathol; 2007 Jul; 26(3):291-7. PubMed ID: 17581414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report.
    Shen Y; Wang Y; Shi Y; Liu J; Liu Y
    Int J Clin Exp Pathol; 2012; 5(1):77-82. PubMed ID: 22295150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seromucinous component in endometrioid endometrial carcinoma as a histological predictor of prognosis.
    Miyamoto M; Takano M; Aoyama T; Soyama H; Yoshikawa T; Tsuda H; Furuya K
    J Gynecol Oncol; 2018 Mar; 29(2):e20. PubMed ID: 29400013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial stromal sarcoma with endometrioid adenocarcinoma of the uterus: a case report.
    Liu G; Zhang C; Ma Z; Zhang Q; Liu B
    Int J Clin Exp Pathol; 2015; 8(5):5242-6. PubMed ID: 26191224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
    Niikura H; Sasano H; Kaga K; Sato S; Yajima A
    Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.